Revvity Inc (RVTY)
112.52
+1.41
(+1.27%)
USD |
NYSE |
Nov 22, 14:33
Revvity Revenue (Quarterly): 684.05M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 684.05M |
| June 30, 2024 | 691.68M |
| March 31, 2024 | 649.92M |
| December 31, 2023 | 695.90M |
| September 30, 2023 | 670.74M |
| June 30, 2023 | 709.07M |
| March 31, 2023 | 674.86M |
| December 31, 2022 | 741.21M |
| September 30, 2022 | 711.80M |
| June 30, 2022 | 895.64M |
| March 31, 2022 | 963.16M |
| December 31, 2021 | 1.028B |
| September 30, 2021 | 861.32M |
| June 30, 2021 | 1.228B |
| March 31, 2021 | 1.308B |
| December 31, 2020 | 235.09M |
| September 30, 2020 | 964.02M |
| June 30, 2020 | 811.72M |
| March 31, 2020 | 652.40M |
| December 31, 2019 | 805.50M |
| September 30, 2019 | 706.92M |
| June 30, 2019 | 722.52M |
| March 31, 2019 | 648.74M |
| December 31, 2018 | 756.35M |
| September 30, 2018 | 674.31M |
| Date | Value |
|---|---|
| June 30, 2018 | 703.36M |
| March 31, 2018 | 643.97M |
| December 31, 2017 | 641.63M |
| September 30, 2017 | 554.28M |
| June 30, 2017 | 546.96M |
| March 31, 2017 | 514.12M |
| December 31, 2016 | 566.77M |
| September 30, 2016 | 514.49M |
| June 30, 2016 | 536.24M |
| March 31, 2016 | 498.02M |
| December 31, 2015 | 450.58M |
| September 30, 2015 | 563.44M |
| June 30, 2015 | 563.91M |
| March 31, 2015 | 526.90M |
| December 31, 2014 | 441.05M |
| September 30, 2014 | 542.05M |
| June 30, 2014 | 556.17M |
| March 31, 2014 | 530.61M |
| December 31, 2013 | 591.87M |
| September 30, 2013 | 522.10M |
| June 30, 2013 | 540.67M |
| March 31, 2013 | 505.38M |
| December 31, 2012 | 562.90M |
| September 30, 2012 | 509.60M |
| June 30, 2012 | 521.79M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
235.09M
Minimum
Dec 2020
1.308B
Maximum
Mar 2021
799.11M
Average
726.51M
Median
Revenue (Quarterly) Benchmarks
| Bionano Genomics Inc | 6.073M |
| Bruker Corp | 864.40M |
| Azenta Inc | 170.06M |
| Harvard Bioscience Inc | 21.97M |
| Akoya Biosciences Inc | 18.81M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 94.37M |
| Total Expenses (Quarterly) | 587.85M |
| EPS Diluted (Quarterly) | 0.77 |
| Enterprise Value | 15.48B |
| Gross Profit Margin (Quarterly) | 56.26% |
| Profit Margin (Quarterly) | 13.80% |
| Earnings Yield | 1.84% |
| Operating Earnings Yield | 2.19% |
| Normalized Earnings Yield | 1.946 |